Postmortem Evaluation of First Trimester Fetal Heart
- PMID: 36815087
- PMCID: PMC9940927
- DOI: 10.12865/CHSJ.48.03.01
Postmortem Evaluation of First Trimester Fetal Heart
Abstract
Due to rapid technology advancement and increasing diagnostic expertise, fetal medicine is rapidly improving. Prenatal diagnostic advancements made it possible to identify structural abnormalities in fetuses as early as the first trimester of pregnancy. However, to validate the echocardiographic diagnosis that led to the pregnancy termination, the termination of pregnancy owing to severe fetal deformities should be audited in accordance with a correct anatomic diagnosis. Following the PRISMA declaration, a systematic literature search was done to find articles on post-mortem first trimester human fetal heart evaluation. Thirteen suitable studies were found using the search method. It is theoretically possible to examine the human fetal heart after death in early pregnancy however these methods are not widely available due the costs associated with the procedure and the equipment, the effects of tissue coloration and distortion brought on by the fixation and contrasting processes (for micro-CT), the current requirement for a skilled operator to acquire, reconstruct, and process the images, and data storage requirements greater than those of conventional clinical scans.
Keywords: Postmortem first trimester fetal heart; congenital heart disease; virtual autopsy.
Copyright © 2022, Medical University Publishing House Craiova.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
References
-
- Garofalo G, Garofalo A, Sochirca O, Alemanno MG, Pilloni E, Biolcati M, Muccinelli E, Viora E, Todros T. Maternal outcomes in first and second trimester termination of pregnancy: which are the risk factors. J Perinat Med. 2018;46(4):373–378. - PubMed
-
- Zhu R, Gan L, Wang S, Duan H. A cohort study comparing the severity and outcome of intrauterine adhesiolysis for Asherman syndrome after first-or second-trimester termination of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019;238:49–53. - PubMed
-
- Hunter LE, Simpson JM. Prenatal screening for structural congenital heart disease. Nat Rev Cardiol. 2014;11(6):323–334. - PubMed
-
- Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. - PubMed
-
- Hafner E, Schuchter K, Liebhart E, Philipp K. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenatal Diagnosis. 1998;18(1):29–34. - PubMed
LinkOut - more resources
Full Text Sources